These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8428370)

  • 21. [The regulation of metallothionein expression and its relationship to zinc].
    Chen WQ; Cheng YY
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):150-3. PubMed ID: 12889151
    [No Abstract]   [Full Text] [Related]  

  • 22. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
    Carter SK; Slavik M
    Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular basis of cadmium toxicity.
    Nath R; Prasad R; Palinal VK; Chopra RK
    Prog Food Nutr Sci; 1984; 8(1-2):109-63. PubMed ID: 6385135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications and inferences of metallothionein structure.
    Vallee BL
    Experientia Suppl; 1987; 52():5-16. PubMed ID: 2959541
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of metallothionein on cell viability and its interactions with cadmium and zinc in HEK293 cells.
    Li J; Liu Y; Ru B
    Cell Biol Int; 2005 Oct; 29(10):843-8. PubMed ID: 16087360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallothioneins and zinc: their functions and interactions.
    Hijova E
    Bratisl Lek Listy; 2004; 105(5-6):230-4. PubMed ID: 15535115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the report of the 1966 Cancer Chemotherapy Collaborative Program Review Committee.
    Richardson AP
    Cancer Treat Rep; 1984 Jan; 68(1):340-1. PubMed ID: 6692434
    [No Abstract]   [Full Text] [Related]  

  • 28. Metallothionein expression and transient resistance to electrophilic antineoplastic drugs.
    Lazo JS; Basu A
    Semin Cancer Biol; 1991 Aug; 2(4):267-71. PubMed ID: 1912530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collection and presentation of combination data.
    Mancher RR
    Cancer Chemother Rep 2; 1974 Mar; 4(1):167-80. PubMed ID: 4826496
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer chemotherapy: new recruits.
    David P
    Nature; 1983 Aug 25-31; 304(5928):675. PubMed ID: 6888533
    [No Abstract]   [Full Text] [Related]  

  • 31. [Past and current problems in tumor research].
    von Wasielewski E; Sedlacek HH
    Dtsch Med Wochenschr; 1986 Apr; 111(16):630-7. PubMed ID: 3956405
    [No Abstract]   [Full Text] [Related]  

  • 32. A murine model of alcoholic cardiomyopathy: a role for zinc and metallothionein in fibrosis.
    Jones WK
    Am J Pathol; 2005 Aug; 167(2):301-4. PubMed ID: 16049317
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemoprevention research at the U.S. National Cancer Institute.
    Greenwald P
    Mil Med; 1994 Jul; 159(7):505-12. PubMed ID: 7816223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cadmium toxicity and distribution in metallothionein-I and -II deficient transgenic mice.
    Conrad CC; Walter CA; Richardson A; Hanes MA; Grabowski DT
    J Toxicol Environ Health; 1997 Dec; 52(6):527-43. PubMed ID: 9397184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 36. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The National Cancer Institute: cancer drug discovery and development program.
    Grever MR; Schepartz SA; Chabner BA
    Semin Oncol; 1992 Dec; 19(6):622-38. PubMed ID: 1462164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer problems lead list for potential medical marijuana research studies.
    Smigel K
    J Natl Cancer Inst; 1997 Sep; 89(17):1255. PubMed ID: 9293912
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism of cadmium, zinc and copper in the rat kidney: the role of metallothionein and other binding sites.
    Petering DH; Loftsgaarden J; Schneider J; Fowler B
    Environ Health Perspect; 1984 Mar; 54():73-81. PubMed ID: 6734573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Function of metallothionein in the body].
    Floriańczyk B
    Postepy Hig Med Dosw; 1996; 50(4):375-82. PubMed ID: 9019746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.